<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Suhail A</submitter><funding>Regional Centre for Biotechnology</funding><funding>DBT/Wellcome Trust India Alliance</funding><funding>Wellcome Trust/DBT</funding><funding>Wellcome Trust</funding><pagination>3522-3538.e7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617169</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(11)</volume><pubmed_abstract>Inflammatory bowel disease (IBD) is a complex autoimmune disorder recently shown to be associated with SUMOylation, a post-translational modification mechanism. Here, we have identified a link between epithelial deSUMOylases and inflammation in IBD. DeSUMOylase SENP7 was seen to be upregulated specifically in intestinal epithelial cells in both human IBD and a mouse model. In steady state, but not IBD, SENP7 expression was negatively regulated by a direct interaction and ubiquitination by SIAH2. Upregulated SENP7 in inflamed tissue displayed a distinct interactome. These changes led to an expansion of localized proinflammatory γδ T cells. Furthermore, in vivo knockdown of SENP7 or depletion of γδ T cells abrogated dextran sulfate sodium (DSS)-induced gut inflammation. Strong statistical co</pubmed_abstract><journal>Cell reports</journal><pubmed_title>DeSUMOylase SENP7-Mediated Epithelial Signaling Triggers Intestinal Inflammation via Expansion of Gamma-Delta T Cells.</pubmed_title><pmcid>PMC7617169</pmcid><funding_grant_id>IA/I/11/2500284</funding_grant_id><pubmed_authors>Gaur P</pubmed_authors><pubmed_authors>Mujagond P</pubmed_authors><pubmed_authors>Ahuja V</pubmed_authors><pubmed_authors>Suhail A</pubmed_authors><pubmed_authors>Singh M</pubmed_authors><pubmed_authors>Awasthi A</pubmed_authors><pubmed_authors>Srikanth CV</pubmed_authors><pubmed_authors>Rizvi ZA</pubmed_authors><pubmed_authors>Ali SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>DeSUMOylase SENP7-Mediated Epithelial Signaling Triggers Intestinal Inflammation via Expansion of Gamma-Delta T Cells.</name><description>Inflammatory bowel disease (IBD) is a complex autoimmune disorder recently shown to be associated with SUMOylation, a post-translational modification mechanism. Here, we have identified a link between epithelial deSUMOylases and inflammation in IBD. DeSUMOylase SENP7 was seen to be upregulated specifically in intestinal epithelial cells in both human IBD and a mouse model. In steady state, but not IBD, SENP7 expression was negatively regulated by a direct interaction and ubiquitination by SIAH2. Upregulated SENP7 in inflamed tissue displayed a distinct interactome. These changes led to an expansion of localized proinflammatory γδ T cells. Furthermore, in vivo knockdown of SENP7 or depletion of γδ T cells abrogated dextran sulfate sodium (DSS)-induced gut inflammation. Strong statistical co</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2026-06-01T16:14:40.275Z</modification><creation>2025-04-03T23:32:42.897Z</creation></dates><accession>S-EPMC7617169</accession><cross_references><pubmed>31825833</pubmed><doi>10.1016/j.celrep.2019.11.028</doi></cross_references></HashMap>